Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 8.86B | 8.84B | 8.10B | 6.03B | 5.74B | 5.94B |
Gross Profit | 1.49B | 1.49B | 1.48B | 1.10B | 1.09B | 1.07B |
EBITDA | 326.86M | 362.85M | 439.00M | 232.07M | 272.80M | 266.56M |
Net Income | 179.98M | 186.98M | 244.84M | 127.93M | 164.36M | 147.25M |
Balance Sheet | ||||||
Total Assets | 4.53B | 4.16B | 4.20B | 4.25B | 3.45B | 3.53B |
Cash, Cash Equivalents and Short-Term Investments | 1.83B | 1.77B | 1.93B | 1.69B | 1.45B | 1.65B |
Total Debt | 876.00M | 380.50M | 446.60M | 552.97M | 356.36M | 442.82M |
Total Liabilities | 2.40B | 1.98B | 2.14B | 2.35B | 1.68B | 1.88B |
Stockholders Equity | 2.13B | 2.18B | 2.06B | 1.90B | 1.77B | 1.66B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 11.21M | 318.49M | 245.53M | -21.99M | 171.09M |
Operating Cash Flow | 0.00 | 22.09M | 324.96M | 251.44M | 82.81M | 193.04M |
Investing Cash Flow | 0.00 | 22.66M | 43.06M | -115.99M | -138.54M | -34.09M |
Financing Cash Flow | 0.00 | -163.85M | -157.37M | 152.47M | -162.19M | 31.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥1.68B | 9.00 | 5.81% | 9.24% | -23.24% | ||
77 Outperform | ¥15.66B | 7.70 | 3.87% | 10.92% | 170.02% | ||
74 Outperform | ¥3.20B | 5.91 | 2.69% | 2.92% | -6.49% | ||
73 Outperform | ¥1.97B | 11.36 | 3.99% | -0.33% | -5.18% | ||
70 Neutral | ¥885.33M | 14.47 | 2.62% | 5.17% | -57.42% | ||
67 Neutral | £2.83B | 10.37 | 4.69% | 3.46% | 2.40% | -24.53% | |
60 Neutral | ¥4.18B | 59.21 | 3.67% | 0.38% | 24.47% |